Lv3
220 积分 2025-06-29 加入
An updated patent review of STAT6 inhibitors and modulators (2020 - present)
1天前
已完结
Clinical trials and new therapies in Sjögren's disease
3天前
已完结
Advances in the diagnosis and treatment of Sjögren disease
3天前
已完结
Insights Into Vepdegestrant (ARV-471): The First-in-Class Estrogen Receptor Proteolysis-Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
7天前
已完结
Indispensable Role of Stat5a in Stat6-Independent Th2 Cell Differentiation and Allergic Airway Inflammation
28天前
已完结
Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function
1个月前
已关闭
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
1个月前
已完结
Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration
1个月前
已完结
Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus
1个月前
已完结
Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice
1个月前
已完结
WSTF nuclear autophagy regulates chronic but not acute inflammation
皖公网安备34019202002308
